Pricing and reimbursement
California’s Medicaid pharmacy “carve-out” set to boost state’s negotiating power, introduce IRP for drugs
California is planning a major overhaul of its Medicaid Pharmacy benefit, called Medi-Cal Rx, that will result in a "carve-out"…
Germany’s ESG Law: A case study for new pharma pricing model
Pharmaceutical pricing is increasingly becoming a broader topic in the global push towards sustainability and environmental, social, and government (ESG)…
Reimbursement outcomes for combination therapies in breast cancer
Combination therapies are particularly common in breast cancer. Data from our PharmOnline International (POLI) database indicate that combination therapies account for 70.3%…
Why are pharma prices changing?
Understanding the reasons behind medicines' price changes has been a common challenge Prices of medicines evolve over time and are…
Japan’s new CEA-based price adjustments set to maintain pricing pressure on innovative drugs
Over the past several years, Japan - which reimburses 99% of all medicines approved in the country - has introduced…
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
US drug prices rise over 4% in 2021 reversing multi-year trend of slowed growth
Usually in January, every year, a large number of pharmaceutical companies update product prices - a trend that often receives…